Summary
Danaher Corporation's first quarter 2016 report highlights significant year-over-year consolidated sales growth of 15.0%, driven primarily by strong contributions from acquisitions, notably the Pall acquisition, which significantly boosted the Life Sciences & Diagnostics segment. Despite this top-line growth, the company is actively preparing for a strategic separation into two independent entities, Danaher and Fortive, expected in the third quarter of 2016. This separation, while creating focused growth companies, also incurred approximately $9 million in separation costs during the quarter. The company's operational performance showed mixed results across segments, with Test & Measurement experiencing a decline in sales from existing businesses, while Environmental, Life Sciences & Diagnostics, and Dental saw modest growth from existing businesses, albeit impacted by currency headwinds and a slightly shorter fiscal quarter.
Financial Highlights
52 data points| Revenue | $3.92B |
| Cost of Revenue | $1.76B |
| Gross Profit | $2.17B |
| R&D Expenses | $226.10M |
| SG&A Expenses | $1.33B |
| Operating Income | $613.10M |
| Interest Expense | $52.90M |
| Net Income | $758.40M |
| EPS (Basic) | $1.10 |
| EPS (Diluted) | $1.09 |
| Shares Outstanding (Basic) | 688.60M |
| Shares Outstanding (Diluted) | 697.10M |
Key Highlights
- 1Consolidated sales increased by 15.0% year-over-year, largely propelled by acquisitions, contributing 16.5% to growth, while sales from existing businesses grew by a modest 0.5%.
- 2The Life Sciences & Diagnostics segment experienced substantial growth, with sales up 42.0% year-over-year, primarily due to the significant impact of the Pall acquisition.
- 3The company is on track to separate into two independent companies, Danaher and Fortive, in Q3 2016, a process which incurred $9 million in separation costs during the quarter.
- 4Operating profit margins saw a slight improvement to 16.4% from 16.1% in the prior year period, driven by higher sales volumes and cost savings initiatives, partially offset by acquisition-related charges and separation costs.
- 5Geographically, high-growth markets led sales growth from existing businesses, representing approximately 25% of total sales in Q1 2016, with China and India showing strength.
- 6The Test & Measurement segment experienced a 5.5% decline in sales, with existing businesses down 5.0%, attributed to an overall market slowdown.
- 7Operating cash flow from continuing operations significantly increased by 46% to $772.8 million, demonstrating strong cash generation despite ongoing strategic initiatives.